WASHINGTON, D.C. (January 26, 2021)—Rep. Mike Thompson (D-California), founder and co-chair of the Congressional Telehealth Caucus, along with caucus Co-Chairs Reps. Peter Welch (D-Vermont), Bill Johnson (R-Ohio) and David Schweikert (R-Arizona) and caucus member Rep. Doris Matsui (D-California)announced the reintroduction of the Protecting Access to Post-COVID-19 Telehealth Act.

NAPERVILLE, Ill. (January 14, 2021)—Distribution of the COVID-19 vaccine is underway across the country, starting with frontline health care workers and those over the age of 65 (or 75 in some areas) or with underlying conditions. Although the rollout in some areas has been slow, hampered by storage issues and political obstacles, community pharmacies are gearing up to help vaccinate the masses. 

WASHINGTON, D.C. (January 15, 2021)—The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), is announcing today that it will be amending the reporting timeline for the Provider Relief Fund Program (PRF) due to the recent passage of the Coronavirus Response and Relief Supplemental Appropriations Act. HHS has been working to provide updated reporting requirements that comply with this recently passed legislation.


DALLAS (January 12, 2021)—A new industry trends report based on a survey conducted by Axxess, a technology provider for care at home, reveals nearly three-quarters of respondents from large care at home organizations indicated their organization would require COVID-19 vaccinations and 90% indicated their organization would increase staff resources for diversity, equity and inclusion in 2021.



AMSTERDAM (November 17, 2020)—Royal Philips, a global provider of health technology, today announced findings from its first ever World COPD Day survey ahead of the awareness day on November 18. Philips surveyed more than 4,000 adults in China, India, Russia and the U.S. to gather insights on global awareness of respiratory conditions, such as chronic obstructive pulmonary disease (COPD), and how the COVID-19 pandemic has influenced overall perceptions of respiratory health.

WASHINGTON, D.C. (November 13, 2020)—The Centers for Medicare & Medicaid Services (CMS) announced that Medicare beneficiaries can receive coverage of monoclonal antibodies to treat coronavirus disease 2019 (COVID-19) with no cost-sharing during the public health emergency (PHE). CMS’s coverage of monoclonal antibody infusions applies to bamlanivimab, which received an emergency use authorization (EUA) from the U.S. Food and Drug Administration on Nov. 9.

MassPACE, the Massachusetts chapter of Programs of All-inclusive Care for the Elderly, has taken an innovative approach to serving its clients, mostly patients who are dual eligible for Medicare and Medicaid, during the pandemic. While traditionally center-based, MassPACE shifted to an at-home model, sending caregivers out with tablets for telehealth and also setting up social activities, counseling and more.